TY - JOUR
T1 - Настанови 2023 року Міжнародної робочої групи з діабетичної стопи, Європейського товариства судинної хірургії, Товариства судинної хірургії щодо захворювання периферичних артерій у пацієнтів із цукровим діабетом і виразкою стопи
AU - Fitridge, Robert
AU - Chuter, Vivienne
AU - Mills, Joseph L.
AU - Hinchliffe, Robert J.
AU - Azuma, Nobuyoshi
AU - Behrendt, Christian Alexander
AU - Boyko, Edward J.
AU - Conte, Michael S.
AU - Humphries, Misty
AU - Kirksey, Lee
AU - McGinigle, Katharin
AU - Niko, Sigrid
AU - Nordanstig, Joakim
AU - Rowe, Vincent
AU - Russell, David
AU - van den Berg, Jos
AU - Venerm, Maarit
AU - Schaper, Nicolaas
PY - 2024/9/30
Y1 - 2024/9/30
N2 - Practical guidelines of the International Working Group on the Diabetic Foot, European Society for Vascular Surgery, Society for Vascular Surgery on the prevention and management of diabetes-related foot disease 2023 Diabetes-related foot complications have become a major cause of morbidity and are implicated in most major and minor amputations globally. Approximately 50% of people with diabetes and a foot ulcer have peripheral artery disease (PAD) and the presence of PAD significantly increases the risk of adverse limb and cardiovascular events. The International Working Group on the Diabetic Foot (IWGDF) has published evidence-based guidelines on the management and prevention of diabetes-related foot complications since 1999. This guideline is an update of the 2019 IWGDF guideline on the diagnosis, prognosis and management of peripheral artery disease in people with diabetes mellitus and a foot ulcer. For this updated guideline the IWGDF, the European Society for Vascular Surgery and the Society for Vascular Surgery decided to collaborate to develop a consistent suite of recommendations relevant to clinicians in all countries. This guideline is based on three new systematic reviews. Using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) framework clinically relevant questions were formulated, and the literature was systematically reviewed. After assessing the certainty of the evidence, recommendations were formulated which were weighed against the balance of benefits and harms, patient values, feasibility, acceptability, equity, resources required, and when available, costs. Through this process five recommendations were developed for diagnosing PAD in a person with diabetes, with and without a foot ulcer or gangrene. Five recommendations were developed for prognosis relating to estimating likelihood of healing and amputation outcomes in a person with diabetes and a foot ulcer or gangrene. Fifteen recommendations were developed related to PAD treatment encompassing prioritisation of people for revascularisation, the choice of a procedure and post-surgical care. In addition, the Writing Committee has highlighted key research questions where current evidence is lacking. The Writing Committee believes that following these recommendations will help healthcare professionals to provide better care and will reduce the burden of diabetes-related foot complications.
AB - Practical guidelines of the International Working Group on the Diabetic Foot, European Society for Vascular Surgery, Society for Vascular Surgery on the prevention and management of diabetes-related foot disease 2023 Diabetes-related foot complications have become a major cause of morbidity and are implicated in most major and minor amputations globally. Approximately 50% of people with diabetes and a foot ulcer have peripheral artery disease (PAD) and the presence of PAD significantly increases the risk of adverse limb and cardiovascular events. The International Working Group on the Diabetic Foot (IWGDF) has published evidence-based guidelines on the management and prevention of diabetes-related foot complications since 1999. This guideline is an update of the 2019 IWGDF guideline on the diagnosis, prognosis and management of peripheral artery disease in people with diabetes mellitus and a foot ulcer. For this updated guideline the IWGDF, the European Society for Vascular Surgery and the Society for Vascular Surgery decided to collaborate to develop a consistent suite of recommendations relevant to clinicians in all countries. This guideline is based on three new systematic reviews. Using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) framework clinically relevant questions were formulated, and the literature was systematically reviewed. After assessing the certainty of the evidence, recommendations were formulated which were weighed against the balance of benefits and harms, patient values, feasibility, acceptability, equity, resources required, and when available, costs. Through this process five recommendations were developed for diagnosing PAD in a person with diabetes, with and without a foot ulcer or gangrene. Five recommendations were developed for prognosis relating to estimating likelihood of healing and amputation outcomes in a person with diabetes and a foot ulcer or gangrene. Fifteen recommendations were developed related to PAD treatment encompassing prioritisation of people for revascularisation, the choice of a procedure and post-surgical care. In addition, the Writing Committee has highlighted key research questions where current evidence is lacking. The Writing Committee believes that following these recommendations will help healthcare professionals to provide better care and will reduce the burden of diabetes-related foot complications.
UR - http://www.scopus.com/inward/record.url?scp=105024761851&partnerID=8YFLogxK
U2 - 10.30978/CEES-2024-3-46
DO - 10.30978/CEES-2024-3-46
M3 - Article
AN - SCOPUS:105024761851
SN - 1818-1384
VL - 2024
SP - 46
EP - 78
JO - Clinical Endocrinology and Endocrine Surgery
JF - Clinical Endocrinology and Endocrine Surgery
IS - 3
ER -